rss
Br J Ophthalmol 87:1453-1458 doi:10.1136/bjo.87.12.1453
  • Clinical science
    • Scientific reports

Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level

Table 2

Treatment results in patients with CSC treated by PDT

Patient No Fluorescein angiographic features at follow up ICG-A features at follow up Size of laser spot applied (ICG-A guided) Diameter of the largest anterior choroidal vessel before PDT Diameter of the same choroidal vessel 3 months after PDT Changes in diameter of the choroidal vessels at 3 months
PED = detachment of the retinal pigment epithelium; RPE = retinal pigment epithelium; CNV = choroidal neovascularisation.
1 No leakage at 1 month, resolution of the PED, ring of RPE atrophy Narrowing of the choroidal vessels, absence of choroidal leakage, PED resolved 3800 μm 622 μm 338 μm −46%
2 No leakage at 1 month, development of a juxtafoveal CNV at 3 months Narrowing of the choroidal vessels, absence of choroidal leakage 2600 μm 545 μm 442 μm −19%
3 No leakage at 1 month, focal RPE window defect Narrowing of the choroidal vessels, absence of choroidal leakage 3000 μm 571 μm 428 μm −25%
4 No leakage at 3 months, diffuse RPE atrophy Narrowing of the choroidal vessels, decreased choroidal leakage 2800 μm 605 μm 382 μm −37%
5 No leakage at 1 month, diffuse RPE atrophy Narrowing of the choroidal vessels, absence of choroidal leakage 3000 μm 470 μm 300 μm −36%
6 No leakage at 1 month, diffuse RPE atrophy Narrowing of the choroidal vessels, decreased choroidal leakage 3200 μm 465 μm 338 μm −27%

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.